10-Qs are only supposed to update us about the fin

10-Qs are only supposed to update us about the financials of the company, not the day-to-day activities and progress. 8-Ks are to tell us about material developments and PRs are what companies should use to keep their investors up to speed about what's going on.

I completely understand your sentiment about being in the dark. I feel as if we should be updated more frequently in regard to where we stand with HemaXellerate as well as dCellVax. I believe that these updates should specify what we have done and what we have left to do as well as timelines to achieve what we have left to do. I'm hoping for a lot more transparency once Regen BioPharma shares go live.

You are also correct about Koos not meeting timelines that he sets forth. He has missed several timelines for achieving HemaXellerate IND approval as well as timelines for preparing dCellVax IND. Perhaps he was a little too confident when he set those timelines.

Everyone who has been here for quite a while, including myself, has gotten fed up with waiting at some point. The science and the hope that it will come to fruition keeps me here. Dr. Ichim has done it before with Medistem, so I know he can do it again.

Good luck and I hope you stick it out!